Russell Investments Group, Ltd.

Position in CRVS — Corvus Pharmaceuticals, Inc.

CIK 1692234 Seattle, WA

Position in CRVS

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$378,534

+$279,124 QoQ

Shares Held

25,337

+272.9% QoQ

Ownership

0.030%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#106

of 172 holders

Holding Since

Mar 2020

8 quarters on record

Voting authority Sole 77% Shared 0% None 23%

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,494,413,888 across 308 Biotechnology names. CRVS ranks #160 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	336,990	$167,393,033
2	REGN	Regeneron Pharmaceuticals, Inc.	230,151	$143,508,345
3	RPRX	Royalty Pharma plc	1,694,250	$94,996,587
4	INCY	Incyte Corp	425,616	$48,247,822
5	ALNY	Alnylam Pharmaceuticals, Inc.	158,228	$47,631,369
6	BMRN	Biomarin Pharmaceutical Inc	783,148	$44,811,725
7	LGND	Ligand Pharmaceuticals Inc	120,304	$38,026,888
8	PTCT	Ptc Therapeutics, Inc.	418,025	$34,098,295

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$378,534	25,337	+272.9%	Shares	Defined	2026-08-06
2026-03-31	$99,410	6,795	+2.0%	Shares	Defined	2026-05-08
2025-12-31	$51,289	6,661	0.0%	Shares	Defined	2026-02-17
2025-09-30	$49,090	6,661	-80.5%	Shares	Defined	2025-11-13
2020-12-31	$121,455	34,117	-7.8%	Shares	Defined	2021-02-08
2020-09-30	$148,425	37,014	-5.5%	Shares	Defined	2020-11-09
2020-06-30	$106,544	39,171	+29.6%	Shares	Sole	2020-08-05
2020-03-31	$63,763	30,220	—	Shares	Defined	2020-05-06
No filing history on record for this holder in this stock.